IHL - INCANNEX - HOLDERS RESEARCH, page-752

Some extra Clinics expansion/rollout goals that were not mentioned in yesterday's announcement.

According to Incannex (ASX:IHL) director and psychedelic clinics business lead Peter Widdows while there is no clear data (yet) to support it, he believes the market opportunity could be around the $2 billion mark in Australia. “That’s working back from the number of people that suffer from certain conditions and then the number who will seek treatment from that and then the estimated pricing,” he said.

“Globally, I think it’s probably closer to a $63 billion market.”

The company is gearing up to launch the country’s first psychedelic-assisted psychotherapy clinic in Melbourne and start treating patients in Q3. “It’s a prototype clinic but it’s a commercial-scale prototype capable of treating 600-plus patients in normal working hours per year – substantially more if we extend the hours,” Widdows said.

“Once we’ve got that running smoothly, we’ll roll out very quickly to other clinics, targeting Sydney first, then probably a second clinic in Melbourne, then Brisbane, Adelaide, Perth, Gold Coast etc., with an eye on the international market as well.

“That’s regulatory conditional, but where regulations change and where we believe there’s a market opportunity, we’ll roll out clinics.” Widdows said there was a real community need for these treatments.
“The effect of depression and PTSD and anxiety on society is very high, and these treatments are showing good clinical results,” Widdows said.
“There’s a real community need for it, it’s a very big market and it will have a very big impact on society.
“The final outcome has always been service delivery to actually provide a proper medical service and make a real difference.”

GLAH